Latest Trials Latest NewsFAQ

University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Agreement Between Arterial, Central Venous, and Peripheral Venous Lactate in the Intensive Care Unit

Not Applicable

Conditions: Blood Lactate Analysis

Interventions: Procedure: Blood Lactate Analysis

First Posted Date: 2012-06-20

Last Posted Date: 2012-06-20

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 50

Registration Number: NCT01624519

Fluoxetine Prevention Trial

Early Phase 1

Withdrawn

Conditions: Cognitive Dysfunction

Interventions: Drug: Fluoxetine
Other: Placebo

First Posted Date: 2012-06-08

Last Posted Date: 2018-10-15

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT01615055

Locations: 🇺🇸
UCLA Medical Center, Los Angeles, California, United States
🇺🇸
City of Hope, Duarte, California, United States

Vilazodone for Treatment of Geriatric Depression

Phase 4

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: Vilazodone; Viibryd
Drug: Paroxetine; Paxil

First Posted Date: 2012-05-31

Last Posted Date: 2018-05-11

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 65

Registration Number: NCT01608295

Locations: 🇺🇸
UCLA Semel Institute, Los Angeles, California, United States

Neuroimaging and Biomarkers in Chronic Visceral Pain

Not Applicable

Completed

Conditions: Irritable Bowel Syndrome

Interventions: Behavioral: Mindfulness based Stress Reduction Training (MBSR)

First Posted Date: 2012-05-21

Last Posted Date: 2018-05-14

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 119

Registration Number: NCT01602575

Locations: 🇺🇸
Oppenheimer Center for Neurobiology of Stress, Los Angeles, California, United States

A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV

Phase 3

Conditions: HIV Dementia

Interventions: Drug: Long acting methylphenidate
Drug: Matched placebo

First Posted Date: 2012-05-16

Last Posted Date: 2012-05-16

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 40

Registration Number: NCT01599975

Locations: 🇺🇸
UCLA CARE Clinic, Los Angeles, California, United States

Starting Treatment With Agonist Replacement Therapies Follow-up Study

Completed

Conditions: Opioid Dependence

First Posted Date: 2012-05-07

Last Posted Date: 2016-08-08

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 877

Registration Number: NCT01592461

Locations: 🇺🇸
NET Steps, Philadelphia, Pennsylvania, United States
🇺🇸
Matrix Institute on Addictions, Los Angeles, California, United States
🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

and more 5 locations

A Parenting and Self-Care Intervention for HIV Infected Mothers

Not Applicable

Completed

Conditions: HIV

Interventions: Behavioral: IMAGE Intervention

First Posted Date: 2012-04-27

Last Posted Date: 2016-11-28

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 124

Registration Number: NCT01586988

Locations: 🇺🇸
UCLA, Isap, Los Angeles, California, United States

Addressing Attitudes to Improve Use of Protective Headwear in Older Adults

Completed

Conditions: Traumatic Brain Injury
Injury of Unknown Intent Due to Fall From Height

Interventions: Behavioral: Social Marketing for protective headgear

First Posted Date: 2012-04-20

Last Posted Date: 2016-05-09

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 37

Registration Number: NCT01582464

Locations: 🇺🇸
Be.Group Facilities, Multiple, California, United States

A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease

Phase 2

Completed

Conditions: Endothelial Dysfunction

Interventions: Drug: Telmisartan

First Posted Date: 2012-04-17

Last Posted Date: 2014-12-08

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 17

Registration Number: NCT01578772

Locations: 🇺🇸
UCLA CARE Center, Los Angeles, California, United States

A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes)

Not Applicable

Completed

Conditions: Diabetes
Heart Failure

Interventions: Drug: Metformin

First Posted Date: 2012-04-10

Last Posted Date: 2020-09-04

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 7

Registration Number: NCT01573949

Locations: 🇺🇸
Ahmanson-UCLA Cardiomyopathy Center, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy